# Nebulized AER101 in Pre-op NSCLC

> **NCT07631299** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Oklahoma** · enrollment: 5 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Stage I
- Non-small Cell Lung Cancer Stage II

## Interventions

- **DRUG:** AER101

## Key facts

- **NCT ID:** NCT07631299
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07631299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07631299, "Nebulized AER101 in Pre-op NSCLC". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07631299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*